OSR Holdings moves towards major licensing deal for oral cancer immunotherapy
Under the proposed terms, Vaximm would secure a $20 million upfront payment, up to $815 million tied to clinical, regulatory, and commercial milestones
Under the proposed terms, Vaximm would secure a $20 million upfront payment, up to $815 million tied to clinical, regulatory, and commercial milestones
The hospital has already onboarded 200+ experienced doctors and is expected to generate 5,000–7,000 jobs
Call it a ray of hope for those enduring the pain of knee osteoarthritis -- the most common form of arthritis, affecting over 300 million people worldwide
It's a development that marks a major step forward for patients struggling with moderate-to-severe chronic spontaneous urticaria
The deal, backed by Gavi and executed by UNICEF, could generate up to US$90 million in savings—enough to provide more than 30 million additional doses
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
The proposed transaction will be effected as a share swap
Consolidated revenue from operations stood at Rs. 111.05 crore
Subscribe To Our Newsletter & Stay Updated